3Seow TK,Liang RC,Leow CK,et al.Hepatocellular carcinoma:from bedside to proteomics[J].Cacer Res,2001,1(10):1249-1263.
4Adilakshmi T,Laine RO.Ribosomal protein S25 mPNA partners with MTF-1,and La to provide a p53-mediated mechanism for survival or death[J].J Biolog Chemi,2002,277(6):4147-4151.
5Poon TC,Yip TT,Yasui Y,et al.Comprehensive proteomic profiling identifies serum proteomic signatures for detection of hepatocellular carcinoma and its subtypes[J].Clin Chem,2003,49:752-760.
6Schwegler EE,Cazares L,Steel LF,et al.SELDI-TOF-MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma[J].Hepatology,2005,41(3):634-642.
7Ward DG,Cheng YN,Kontchou G,et al.Changes in the serum proteome associated with the development of hepatocellular carcinoma in hepatitis C-related cirrhosis[J].Br J Cancer,2006,94(2):287-292.
8Fung Eric T,Enderwick C.Proteinchip and clinical proteomics:computational challenges and solutions[J].Computational Proteomics Supplement,2002,3(32):34-41.
9Melle C,Kaufmann R,Hommann M,et al.Proteomic profiling in microdissected hepatocellular carcinoma tissue using protein chip technology[J].Int J Oncol,2004,24(4):885-891.
7Petricoin EF,Ardekani AM,Hitt BA,et al.Use of proteomic patterns in serum to identify ovarian cancer[J].Lancet,2002,359(9306):572.
8Li J,Zhang Z,Rosenzweig J,et al.Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer[J].Clin Chem,2002,48(8):1296.
9Banez LL, Prasanna P, Sun L. Diagnostic potential of serum proteomic patterns in prostate cancer[J].J Urol,2003,170(2 Pt 1):442.
10Michael C,Kew.Hepatic tumors and cysts.In:Sleisenger M,Scharschmidt BF.Fordtran MH (eds),Sleisenger and Fordtran's gastrointestinal and liver disease[M].sixth Edition,vol 2.W.B.Saunders,1998:1368.
